The link between alcohol and epilepsy

Scientists from Pusan National University in South Korea are conducting an updated analysis to clarify if alcohol drinkers may be at higher risk of developing epilepsy and unprovoked seizures.

Existing meta-analyses indicate that alcohol consumption leads to an increased risk of epilepsy, but recent cohort studies contradict these findings.  An updated meta-analysis to clarify these discrepancies found an overall positive association between alcohol consumption and epilepsy. However, scientists advise that further cohort studies in wider settings are required to establish this association.

Epilepsy, a common neurological disorder associated with stigma, psychiatric comorbidities, and rising healthcare costs, affects approximately 50 million people globally. A common risk factor associated with the development of epilepsy and seizures is alcohol consumption.

Various studies have focused on how alcohol consumption leads to provoked seizures, commonly occurring due to alcohol withdrawal, or heavy alcohol intoxication. However, very few of these focus on the link between alcohol consumption and unprovoked seizures. One such study was a meta-analysis conducted in 2010, which analyzed six case-control studies and found that alcohol users were more prone to developing unprovoked seizures.

Interestingly, data from recent cohort studies contradict these findings, implying that there is no association between alcohol intake and epilepsy.

Now, using more accurate diagnostic methods and recent data, the team of scientists led by Professor Kyoung Nam Woo and including Professor Yun Hak Kim from Pusan National University, conducted an updated meta-analysis to conclusively clarify the relationship between alcohol consumption and unprovoked seizures and epilepsy.

For this meta-analysis, which was made available online in the Drug and Alcohol Dependence journal on January 11, 2022, the team included a total of eight studies, comprising five case-control studies and three cohort studies. Further, they conducted a cubic spline analysis on data extracted from these studies, to assess the dose-response relationship between alcohol intake and epilepsy.

The findings suggested that overall, alcohol drinkers were at a significantly higher risk of developing epilepsy, as compared to non-drinkers. A significant positive dose-response relationship was found upon analysis of case-control studies, implying that the risk of epilepsy increases with an increase in alcohol intake. These findings are consistent with previous meta-analyses.

An important finding was that cohort studies did not show a positive association between alcohol intake and epilepsy. In fact, two out of three cohort studies suggested that alcohol intake reduces the risk of epilepsy.

“Further large cohort studies of the general population are required to assert a definite causal relationship between alcohol consumption and epilepsy and to identify a potential threshold,” says Professor Kim. Moreover, since cohort studies include more subjects, and are less prone to biases, they comparatively provide more accurate relationships between exposure and development of a disorder.

An assessment of the risk of alcohol consumption in various clinical situations, such as types of CNS insult and the time relation of alcohol consumption with seizures, will be important for primary prevention. To increase the applicability to the general population, future studies should be conducted in which the potential confounders such as age, sex, and smoking have been adjusted, says Professor Woo, highlighting the long-term implications of this work.

Once clarity is achieved, assessment of the risk of alcohol consumption in different clinical situations will be an effective step for the prevention of epilepsy in the general population.

 

 

 

Must Read

MM2024: Australia’s largest (and greenest) scientific pharmacy conference ignites in Adelaide

0
Medicines Management 2024 opens with strong sustainability focus, a new international partnership and release of the long-awaited AdPha Clinical Pharmacy Standards. Advanced Pharmacy Australia (AdPha)’s...